Onkologie. 2015:9(5):248-250

Treatment of chronic and breakthrough pain at pancreas tumor patient

Štěpán Bejvančický1, Petra Bejvančická2
1 Centrum pro léčbu bolesti, Klinika anesteziologie, resuscitace a intenzivní medicíny FN Plzeň
2 Fakulta zdravotnických studií, Západočeská univerzita v Plzni

Case report presents use of new possibility treatment of breakthrough pain, it advantage and comparison to older one, „classical treatment“, still

most used medication treatment. It presents just available fentanyl immediate drugs on Czech medical market, their indications and limitations.

Keywords: breakthrough pain, fentanyl, cognitive disorder, OIC-opioid induced constipation

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bejvančický Š, Bejvančická P. Treatment of chronic and breakthrough pain at pancreas tumor patient. Onkologie. 2015;9(5):248-250.
Download citation

References

  1. Kabelka L, Kozák J, Lejčko J, Sláma O. Doporučený postup pro léčbu průlomové bolesti. Bolest 2011; 14(Supplementum 1).
  2. Fricová J. Současné možnosti léčby průlomové bolesti u onkologických pacientů. Remedia, 2011; 21: 14-19.
  3. Nauck F, Eulitz N. Tumorschmerzterapie. Der Schmerz 2007; 21: 359-372. Go to original source... Go to PubMed...
  4. Davis MP, Walsh D, Lagman R, et al. Controversies in pharmacotherapy of pain management. Lancet Oncol 2005; 6: 696-704. Go to original source...
  5. Davies AN, Vriens J, Kennett A, McTaggart M. An observational study of oncology patients' utilization of breakthrough pain medication. J Pain Symptom Manage 2008; 35: 406-411. Go to original source...
  6. Bertram L. Erfahrung vom Tumorpatientem mit Durchbruchsmerzen und medicamentosen Behandlung. Der Schmerz 2010; 24: 605-612. Go to original source... Go to PubMed...
  7. Lejčko J, Doležal T. Fentanyl ve formě nosního spreje. Farmakoterapie, 2010; 149-151.
  8. Slatkin N, Xie, F. Messina. Fentanyl Buccal Tablet for Relief of Breathrough Pain in Opioid-Tolerant Patients with Cancer-Related Chronic Pain. The Journal of Supportive Oncology, 2007; 5: 327-334. Go to PubMed...
  9. Mikroverze AISLP - 2015.1




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.